Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adultsZachary S. Wallace, Hyon K. Choi, Gandarvaka Miles et al.|Annals of the Rheumatic Diseases|2023Cited by 95
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United StatesZachary S. Wallace, Hyon K. Choi, Ekaterina Smolkina et al.|Lara D. Veeken|2024Cited by 9
A real-world analysis of the clinical and healthcare burden associated with osteogenesis imperfectaKenneth I. Berger, Gandarvaka Miles, Natalia Petruski‐Ivleva et al.|Bone|2025Cited by 5
Fabry disease pre-treatment patterns in United States claims dataAlexandra Dumitriu, Roberto Araujo, Gandarvaka Miles et al.|Molecular Genetics and Metabolism|2024Cited by 0
Pre- and post-diagnosis journey among commercially insured male and female Fabry disease patients in the United StatesAlexandra Dumitriu, Natalia Petruski‐Ivleva, И. А. Максимова et al.|Molecular Genetics and Metabolism|2024Cited by 0